![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » EpiPen Recalled Due to Administration Defect
EpiPen Recalled Due to Administration Defect
Meridian Medical Technologies issued an international recall for its EpiPen auto-injectors, because the devices may contain a defective part that could cause a failure to activate or require increased force to activate.
Two reports have been confirmed of the device failing to activate, from a batch of approximately 80,000 devices. The recall was for one lot (#5FA665) of branded EpiPen Auto-Injectors, not the generic product. The lot was distributed to Australia, New Zealand, Europe and Japan only.
The company said batch numbers: 5FA665, 5FA6651, 5FA6652 or 5FA6653, with an expiration date of April 17, need to be replaced as soon as possible.
The device treats anaphylaxis, which can be life-threatening. — Cynthia Jessup
Updated: March 27, 2017 at 2:03 p.m.
Upcoming Events
-
18Jul
-
21Oct